Literature DB >> 13257939

Nitrofurantoin; clinical and laboratory studies in urinary tract infections.

W A RICHARDS, E RISS, E H KASS, M FINLAND.   

Abstract

Entities:  

Keywords:  FURAN DERIVATIVES/therapeutic use; URINARY TRACT/infections

Mesh:

Substances:

Year:  1955        PMID: 13257939     DOI: 10.1001/archinte.1955.00250150011001

Source DB:  PubMed          Journal:  AMA Arch Intern Med        ISSN: 0888-2479


× No keyword cloud information.
  11 in total

1.  AN ASSESSMENT OF AMPICILLIN IN THE TREATMENT OF URINARY TRACT INFECTION.

Authors:  W BRUMFITT; D A LEIGH; A PERCIVAL; J D WILLIAMS
Journal:  Postgrad Med J       Date:  1964-12       Impact factor: 2.401

2.  Recent advances in the treatment of renal disease.

Authors:  A G SPENCER
Journal:  Postgrad Med J       Date:  1959-11       Impact factor: 2.401

3.  The sensitivity of Proteus to nitrofurantoin in vitro.

Authors:  P W KIPPAX
Journal:  J Clin Pathol       Date:  1957-05       Impact factor: 3.411

4.  Proteus infection of urinary tract, with special reference to treatment with nitrofurantoin.

Authors:  J E MIDDLETON
Journal:  Br Med J       Date:  1957-08-31

5.  Nitrofurantoin in chronic urinary infection associated with renal calculi.

Authors:  M G MCGEOWN
Journal:  Br Med J       Date:  1956-08-04

6.  Potential unreliability of nitrofurantoin disks in susceptibility testing.

Authors:  R Hoo; W L Drew
Journal:  Antimicrob Agents Chemother       Date:  1974-06       Impact factor: 5.191

7.  [Damage to the nervous system due to nitrofurans in the rat].

Authors:  G W Klinghardt
Journal:  Acta Neuropathol       Date:  1967-08-02       Impact factor: 17.088

8.  Hepatic injury associated with nitrofurantoin therapy.

Authors:  L I Goldstein; K G Ishak; W Burns
Journal:  Am J Dig Dis       Date:  1974-11

9.  Minimal inhibitory concentrations of 19 antimicrobial agents for 96 clinical isolates of group IVe bacteria.

Authors:  W D Welch; R K Porschen; B Luttrell
Journal:  Antimicrob Agents Chemother       Date:  1983-09       Impact factor: 5.191

10.  Inhibition of primary ADP-induced platelet aggregation in normal subjects after administration of nitrofurantoin (furadantin).

Authors:  E C Rossi; N W Levin
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.